Stay updated with breaking news from Phase Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 382,800 shares, a growth of 23.5% from the March 31st total of 309,900 shares. Based on an average trading volume of 45,200 shares, the days-to-cover ratio is […]
Disc Medicine Opco (NASDAQ:IRON – Get Rating) and ProPhase Labs (NASDAQ:PRPH – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, earnings, risk and institutional ownership. Institutional and Insider Ownership 75.4% of Disc Medicine […]
Disc Medicine Opco (NASDAQ:IRON – Get Rating) and ProPhase Labs (NASDAQ:PRPH – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability. Volatility and Risk Disc Medicine Opco has a […]
GARDEN CITY, NY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a growth oriented and diversified diagnostics,...
Operator: Good morning, afternoon, evening, and welcome to the ProPhase Labs Third Quarter 2022 Financial Results Conference Call. All participants will be in listen-only mode.